Special Considerations and Clinical Management of HIV in Patients With Substance Use Disorder

  • Author: Frederick L. Altice, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 2/5/20 (What's New)

Summary

  • Reduction in drug-use frequency and safer injection practices are more realistic goals than complete cessation for many people with substance use disorder until abstinence can be achieved
  • Provision of drug-use paraphernalia and education are essential HIV risk–prevention services for individuals with substance use disorder (Management Guidelines)[CDC Intervention]
  • PWIDs should be routinely screened for HBV, HCV, latent TB infection, syphilis, and other STDs, and offered pneumococcal, influenza, tetanus, and HBV immunization, and (when appropriate) prophylaxis for TB (Management Guidelines)[Aberg 2014]

Action required

Keywords: Initial Antiretroviral Therapy, IV Drug Use, Special Populations

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.